Stocks TelegraphStocks Telegraph
Stock Ideas

ST Premium

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!

SRPT Financial Statements and Analysis

NASDAQ : SRPT

Sarepta Therapeutics, Inc.

$63.82
-6.59-9.36%
At Close 4:00 PM
61.3
BESG ScoreESG Rating

SRPT FINANCIAL STATEMENTS

An instrumental part of fundamental analysis is measuring key indicators of an asset, which are the factors that can influence its value and price. However, sometimes investors show more interest in financial statements with other factors to determine whether investing in that company is the right decision. Financial statements of a company include:

  • Balance Sheet
  • Income Statement
  • Cash Flow Statement

SRPT Income Statement

A company's income statement helps investors and business owners determine whether the company is profitable or losing money. Profitability is a key factor investors consider before investing in a stock. Income statements provide them with information about a company's profitability over time. The statement also enables them to observe trends in company spending and earnings since it breaks down individual costs and revenues. Income statements also provide details on where a company's money is going when it isn't profitable or its profits fluctuate.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
revenue467.172M362.931M413.464M396.781M331.817M
cost of revenue91.691M53.264M50.559M44.176M37.026M
gross profit375.481M309.667M362.905M352.605M294.791M
gross profit ratio0.8040.8530.8780.8890.888
research and development expenses224.483M173.708M194.35M195.517M194.301M
general and administrative expenses128.20M138.796M127.003M350.171M120.893M
selling and marketing expenses0-2.136M0-218.471M0
selling general and administrative expenses128.20M136.66M127.003M131.70M120.893M
other expenses602.00K268.00K194.35M763.00K-425.00K
operating expenses353.285M310.368M328.00M327.98M315.633M
cost and expenses444.976M363.632M378.559M372.156M352.659M
interest income18.333M18.842M19.897M-50.555M22.822M
interest expense4.918M4.832M4.166M-16.776M5.229M
depreciation and amortization9.806M12.731M12.696M-52.055M10.928M
ebitda48.73M12.03M58.31M-28.46M12.483M
ebitda ratio0.1040.0330.156-0.0720.038
operating income22.196M-701.00K34.905M24.625M-20.842M
operating income ratio0.048-0.0020.0840.062-0.063
total other income expenses net11.81M14.278M6.543M15.746M-29.925M
income before tax34.006M13.577M41.448M40.371M-33.174M
income before tax ratio0.0730.0370.100.102-0.10
income tax expense395.00K7.117M5.329M-5.284M7.763M
net income33.611M6.46M36.119M45.655M-40.937M
net income ratio0.0720.0180.0870.115-0.123
eps0.350.0680.380.49-0.46
eps diluted0.330.0680.370.43-0.46
weighted average shs out95.39M94.618M93.991M93.617M88.889M
weighted average shs out dil100.448M94.618M99.114M105.594M88.889M
Graph

SRPT Balance Sheet

Balance sheet summarizes a company's financials and can be used as a basis by investors to determine the value of a company. It shows the value of the stock, as well as the assets and liabilities of the company. A company's balance sheet displays how its assets are put to use and how those assets are financed, based on the liabilities section. Both investors and analysts analyze a company's balance sheet to determine how it allocates its resources.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
cash and cash equivalents197.855M383.622M427.29M428.43M541.932M
short term investments1.001B1.077B963.453M1.248B1.192B
cash and short term investments1.198B1.46B1.391B1.676B1.734B
net receivables515.987M392.26M419.381M439.706M354.263M
inventory565.924M485.795M373.53M322.859M244.011M
other current assets405.069M345.107M281.211M140.516M13.669M
total current assets2.685B2.684B2.465B2.579B2.451B
property plant equipment net446.686M400.201M375.571M357.106M345.821M
goodwill00000
intangible assets028.252M28.93M29.62M19.501M
goodwill and intangible assets028.252M28.93M29.62M19.501M
long term investments181.77M23.185M41.376M22.106M13.448M
tax assets0015.579M-1.0081.061M
other non current assets286.109M288.983M298.064M276.413M199.027M
total non current assets914.565M740.621M759.52M685.245M658.858M
other assets0001.000
total assets3.60B3.424B3.224B3.265B3.11B
account payables118.774M107.417M91.536M164.918M87.948M
short term debt91.595M91.505M105.586M123.328M322.35M
tax payables14.696M18.186M18.292M13.766M24.677M
deferred revenue127.001M122.036M112.00M50.416M22.494M
other current liabilities347.423M349.346M281.295M314.997M17.951M
total current liabilities699.489M688.49M608.709M653.659M450.743M
long term debt1.306B1.278B1.274B1.133B1.372B
deferred revenue non current0325.00M325.00M437.00M485.00M
deferred tax liabilities non current0143.601M140.102M140.965M0
other non current liabilities373.40M55.287M55.722M41.10M38.10M
total non current liabilities1.679B1.659B1.654B1.752B1.895B
other liabilities00000
capital lease obligations170.009M143.601M140.102M140.965M134.752M
total liabilities2.379B2.347B2.263B2.405B2.345B
preferred stock00000
common stock10.00K10.00K9.00K9.00K9.00K
retained earnings-4.37B-4.404B-4.41B-4.446B-4.492B
accumulated other comprehensive income loss2.245M-1.03M-691.00K918.00K-638.00K
other total stockholders equity5.589B5.482B5.372B5.305B5.257B
total stockholders equity1.221B1.077B961.192M859.337M764.357M
total equity1.221B1.077B961.192M859.337M764.357M
total liabilities and stockholders equity3.60B3.424B3.224B3.265B3.11B
minority interest00000
total investments1.182B1.10B963.453M1.27B1.192B
total debt1.398B1.37B1.379B1.397B1.372B
net debt1.20B986.294M952.058M968.378M829.575M
Graph

SRPT Cash Flow

A cash flow statement is regarded as a valuable indicator of profitability and the long-term outlook for a company. It assists the company in evaluating whether it has sufficient funds to cover its expenses. Essentially, a cash flow statement represents an organization's financial health. The cash flow statement, which measures the business's ability to operate in the short as well as long term, is broken down into operating, investing, and financing activities.

DateSep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023
reported currencyUSDUSDUSDUSDUSD
calendar year20242024202420232023
periodQ3Q2Q1Q4Q3
deferred income tax000-11.043M18.722M
stock based compensation43.45M50.482M40.692M45.826M48.061M
change in working capital374.989M-45.378M-329.611M-150.29M-154.712M
accounts receivables-74.527M18.809M21.521M-81.472M-82.047M
inventory-70.539M-102.46M-60.512M-94.104M-26.612M
accounts payables1.685M77.593M-92.843M61.088M-23.558M
other working capital237.097M-39.32M-197.777M-35.802M-22.495M
other non cash items-524.591M72.649M474.141M-36.00K3.232M
net cash provided by operating activities-70.699M14.942M-242.076M-54.657M-114.706M
investments in property plant and equipment-27.263M-29.167M-42.444M-19.039M-40.912M
acquisitions net00011.239M-11.239M
purchases of investments-389.402M-330.832M-216.45M-573.536M-645.605M
sales maturities of investments297.84M261.471M477.69M528.217M475.807M
other investing activites-10.00M-69.361M251.24M-11.239M11.378M
net cash used for investing activites-128.825M-98.528M218.796M-64.358M-210.571M
debt repayment000-129.832M0
common stock issued-47.873M39.918M22.14M1.943M15.405M
common stock repurchased00000
dividends paid00000
other financing activites61.63M39.918M22.14M129.832M15.405M
net cash used provided by financing activities13.757M39.918M22.14M1.943M15.405M
effect of forex changes on cash0003.57M0
net change in cash-170.188M-43.668M-1.14M-113.502M-309.872M
cash at end of period213.434M383.622M427.29M428.43M561.081M
cash at beginning of period383.622M427.29M428.43M541.932M870.953M
operating cashflow-70.699M14.942M-242.076M-54.657M-114.706M
capital expenditure-27.263M-29.167M-42.444M-19.039M-40.912M
free cash flow-97.962M-14.225M-284.52M-73.696M-155.618M
Graph

Frequently Asked Questions

How did Sarepta Therapeutics, Inc. do last quarter? What was its Total Revenue and Cost of Revenue?
A company's Total Revenue reveals how much money it generates before any expenses or deductions are made. As a result, this metric informs investors/stakeholders how much money the business makes. Tracking and understanding it is essential for evaluating a company's growth. As opposed to revenue, Cost of Revenue is any expenses a business incur to generate revenue. There can be high revenue in a business, but if the costs are high, it won't make a profit and will go out of business when money runs out. Therefore, SRPT generated $467.17M in revenue last quarter, while its costs came in at $91.69M.
Last quarter, how much Gross Profit did Sarepta Therapeutics, Inc. report?
A business's Gross Profit is a key indicator of its profitability and financial performance. In other words, it reflects how efficiently a business uses labor, raw materials, and other resources. Sarepta Therapeutics, Inc. reported a $375.48M Gross Profit for the quarter ended Sep 30, 2024.
Have SRPT's Total Operating Expenses and Operating Income been favorable recently?
Operational Expenses represent the costs a company must incur to generate revenue, which is the ultimate goal of a business, whereas Operating Income shows the revenue left after operational direct and indirect costs have been deducted. SRPT incurred $353.29M worth of Operating Expenses, while it generated $22.20M worth of Operating Income.
How much Net Income has SRPT posted recently?
The Net Income of a company is one of the factors investors consider when investing in the company. According to recent earnings report from Sarepta Therapeutics, Inc., the company generated $33.61M in Net Income. When a company has a history of consistent net income, investors are more likely to invest in it since they know they will get a return.
At the end of the last quarter, how much Cash and Equivalents did Sarepta Therapeutics, Inc. have?
The amount of Cash and Cash Equivalents is an effective indicator of the financial strength and well-being of a company. An excess cash situation occurs when a company has more cash and cash equivalents than it needs for operating activities. The amount of Cash and Cash Equivalents available to Sarepta Therapeutics, Inc. as of the end of the last quarter was $197.86M.
What are SRPT's Total Net Receivables for the last quarter?
Total Net Receivables are a company's outstanding debts to its customers. Therefore, it refers to the amount that a company expects to collect from its customers. The higher a company's net receivables are, the more confident it is that it can collect money from its debtors. As of the end of the last quarter, SRPT had Total Net Receivables of $515.99M.
In terms of Total Assets and Current Assets, where did Sarepta Therapeutics, Inc. stand at?
An asset with an economic value within a year is considered a current asset. Total assets, however, also include long-term fixed assets, intangible assets, and other non-current assets. The current Assets of SRPT were $2.69B, while the Total Assets stand at $3.60B.
As of the last quarter, how much Total Debt did Sarepta Therapeutics, Inc. have?
The total debt of a business refers to how much it borrows. A company's current and long-term liabilities are added together to calculate its Total Debt. A debt ratio may be taken into account on a balance sheet by financial lenders, investors, and business leaders when making informed decisions about future loans or investments. The total amount of SRPT's debt was $1.40B at the end of the last quarter.
What were SRPT's Total Liabilities during the last reported quarter?
A company's total liabilities are the sum of all debts it is liable for, including any off-balance shee liabilities it may incur. This can be calculated by adding up all short-term and long-term liabilities. In its last quarter, SRPT reported total liabilities of $2.38B.
How much did SRPT's Working Capital change over the last quarter?
Working Capital Change for SRPT was $374.99M over the last quarter. Working Capital Change refers to the difference between net working capital amounts at the end of one accounting period and the end of another. It tells investors/stakeholders how much the company's cash flow will differ from its Net Income (i.e., after-tax profits). More powerful companies often have positive Change in Working Capital numbers as they have increased control over collecting cash from customers and delaying payments to suppliers.
SRPT generated how much cash from operating activities?
An operating cash flow statement usually contains cash from operating activities in the first section. An organization's cash from operating activities refers to the money it takes in and takes out as a result of its regular business operations. SRPT generated -$70.70M of Cash from Operating Activities during its recently reported quarter.
What was SRPT's latest reported Net Change in Cash?
An increase or decrease in cash and cash equivalent balances within a specified period is considered the net change in cash in a cash flow statement. Furthermore, it takes into account cash changes as a result of investments, financing, and operating activities. SRPT reported a -$170.19M Net Change in Cash in the most recent quarter.
logo

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com

stockstelegraph

Don't have an account?

stockstelegraph

Don't have an account?

stockstelegraph

Already have an account?

stockstelegraph
Smart Screening Tools for Exceptional Returns
stockstelegraph

For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.

Ready to Win Big?

Try Now for Just $1!
stockstelegraph